Another new report confirms small excess risk of GLP-1 drugs for NAION, a vision-threatening condition (acronym for nonarteritic anterior ischemic optic neuropathy) acpjournals.org/doi/epdf/10.73 Another new report confirms small excess risk of GLP-1 drugs for NAION, a vision-threatening condition (acronym for nonarteritic anterior ischemic optic neuropathy) acpjournals.org/doi/epdf/10.73 Thanks @EricTopol
Zepbound may not be appropriate if you are pregnant, breastfeeding, have a history of thyroid cancer, thyroid disorders, gallbladder disease, or pancreatitis
8892 Oxidative stress is well known to be a major contributor of the pathophysiology of hypertensive nephropathy
Looking ahead, the most noticeable effects are likely to be higher prices, increased drug shortages, and reduced access for patientsespecially for generics and high-demand specialty drugs
Comparisons and related research compounds
Studies in isolated islets and in vivo models suggest that GIP and GLP-1 receptor activation can work through distinct but complementary pathways to enhance beta cell function
